title: [Chemotherapy of advanced urological tumors].
abstract: The indication for chemotherapy is quite different in urological malignancies. In case of testicular tumors the availability of chemotherapy is one of the milestones in their successful treatment. Patients with low-volume metastases will be cured in nearly 100% and even far advanced disease can be cured in more than 50%. Contrarily in renal cell carcinoma chemotherapy is without any significance, response rates are <8%. Comparable is the situation in penile cancer. Though in hormone-refractory prostate cancer chemotherapy also can not prevent further disease progression, it shows good palliative effects.
authors: Urologische Universitätsklinik Essen, Deutschland.
authors: S
authors: S
authors: Krege
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D015996:Survival Rate; D016896:Treatment Outcome; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents